Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-temperature-resistant fiber-based aerogel composites for dynamic capture of low-concentration radioactive iodine vapor: Theoretical calculations and experimental validation.

Journal of hazardous materials·2026
Same author

Association of Pre-Transplant Tyrosine Kinase Inhibitor Therapy With Tumor Response and Survival in Hepatocellular Carcinoma: A 10-Year Retrospective Cohort Study of 427 Patients.

World journal of surgery·2026
Same author

Neohesperidin Regulates Lipid Metabolism and Ameliorates MASLD by Targeting ECHS1.

Phytotherapy research : PTR·2026
Same author

The impact of regressed endometrial hyperplasia on reproductive outcomes following frozen embryo transfer: a propensity score-matched cohort study.

Frontiers in endocrinology·2026
Same author

Robust Heterojunction Nanoconstructs Enable Precise Decipherment of Aqueous Humor Metabolic Profiles in Multiple Retinal Diseases.

Analytical chemistry·2026
Same author

Development of a core outcome set for traditional Chinese medicine for atrial fibrillation.

Frontiers in pharmacology·2026

Related Experiment Video

Updated: Dec 10, 2025

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.3K

Arrb2 promotes endothelial progenitor cell-mediated postischemic neovascularization.

Xuelian Wang1,2, Gaojian Huang1,2, Jiaxin Mu3

  • 1Department of Pharmacy, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Theranostics
|September 1, 2020
PubMed
Summary

Beta-arrestin 2 (Arrb2) promotes endothelial progenitor cell (EPC) function and blood vessel formation. Enhancing Arrb2 levels in EPCs could be a therapeutic strategy for ischemic vascular diseases.

Keywords:
angiogenesisendothelial progenitor cellshind-limb ischemianeovascularizationβ-arrestin 2

More Related Videos

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

10.1K
Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
13:46

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

16.6K

Related Experiment Videos

Last Updated: Dec 10, 2025

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.3K
Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
07:34

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits

Published on: June 2, 2019

10.1K
Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
13:46

Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood

Published on: April 13, 2012

16.6K

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine
  • Regenerative Medicine

Background:

  • Endothelial progenitor cells (EPCs) are crucial for therapeutic angiogenesis in ischemic vascular diseases.
  • Modulating EPC biological functions is key for effective treatment strategies.

Purpose of the Study:

  • To investigate the role of beta-arrestin 2 (Arrb2) in EPC biology.
  • To elucidate the molecular mechanisms by which Arrb2 influences EPC function and angiogenic therapy.

Main Methods:

  • Evaluated Arrb2's influence on postischemic neovascularization in Arrb2-deficient mice.
  • Analyzed EPC proliferation, apoptosis, and function in vitro with Arrb2 manipulation.
  • Investigated Arrb2's effect on EPC-mediated neovascularization in a hind-limb ischemia (HLI) mouse model.

Main Results:

  • Arrb2 deficiency impaired blood flow recovery and capillary density in mice after HLI.
  • In vitro, Arrb2 overexpression enhanced EPC proliferation, migration, adhesion, and tube formation.
  • Arrb2 activated extracellular signal-regulated kinase (ERK)1/2 and protein kinase B (Akt) pathways, improving EPC function and therapeutic potential.

Conclusions:

  • Arrb2 enhances EPC-mediated neovascularization by activating ERK and Akt signaling pathways.
  • Arrb2 represents a novel therapeutic target for promoting EPC function in ischemic vascular diseases.